|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02279 YONGHE MEDICAL
Nominal 
2.900 +0.180 (+6.618%) | 2024/12 - Final RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | 228,615 | (17,153) | (108,562) | 437,281 | 501,571 |
| Net Cash from / (used in) Investing Activities | (53,261) | 245,582 | (650,565) | (193,944) | (142,388) |
| Net Cash from / (used in) Financing Activities | (290,717) | (185,204) | (333,054) | 1,028,222 | (156,116) |
| Increase / (Decrease) in Cash & Cash Equivalents | (115,363) | 43,225 | (1,092,181) | 1,271,559 | 203,067 |
| Cash & Cash Equivalents at beginning of period | 603,215 | 565,093 | 1,566,192 | 292,856 | 89,789 |
| Effect of Foreign Exchange Rate Changes | (10) | (5,103) | 91,082 | 1,777 | 0 |
| Others | 0 | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | 487,842 | 603,215 | 565,093 | 1,566,192 | 292,856 |
| Remarks: | Real time quote last updated: 23/07/2025 18:00 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -226,343 |
| %Change | -58.575% |
| EPS / (LPS) | RMB -0.450 |
| NBV Per Share (¥) | RMB 1.360 |